Assistant Professor, Obstetrics and Gynecology, Weill Cornell Medical College
Obstetrics & Gynecology
Dr. Ginger Gardner, MD
|
|
Give Review
Ginger Gardner is an expert in the field of Obstetrics & Gynecology. She went to medical school at Boston University School of Medicine. Boston University School of Medicine is ranked 30 in research and 52 in primary care medicine She over the years received 1 awards: "Fellow (FACOG)". Ginger Gardner is a published doctor. She has 64 publications published. The most current publication "Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery." She accepts Medicare payments and is registered with Medicare.gov.
Publications
- Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian Cancer at a comprehensive Cancer center.
- Herniation formation in women undergoing robotically assisted laparoscopy or laparotomy for endometrial Cancer.
- Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery.
- Is It Time to Centralize Ovarian Cancer Care in the United States?
- A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulki...
- Cost-effectiveness analysis of robotically assisted laparoscopy for newly diagnosed uterine Cancers.
- The feasibility and safety of same-day discharge after robotic-assisted hysterectomy alone or with other procedures for benign and malignant indications.
- Detection of Sentinel Lymph Nodes in Minimally Invasive Surgery Using Indocyanine Green and Near-Infrared Fluorescence Imaging for Uterine and Cervical Malignancies.
- Fellowship learning curve associated with completing a robotic assisted total laparoscopic hysterectomy.
- Clinical Outcome of Isolated Serous Tubal Intraepithelial Carcinomas (STIC).
- Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian Cancer: Risk factors and associations with post-operative morbidity.
- Postoperative Pain Medication Requirements in Patients Undergoing Computer-Assisted ("Robotic") and Standard Laparoscopic Procedures for Newly Diagnosed Endometrial Ca...
- Optimal (â¤1cm) but visible residual disease: Is extensive debulking warranted?
- Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial Cancer.
- Tumoral displacement into fallopian tubes in patients undergoing robotically assisted hysterectomy for newly diagnosed endometrial Cancer.
- Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial Cancer.
- Management of Uterine adenosarcomas with and without sarcomatous overgrowth.
- Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial Cancer.
- Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial Cancer.
- Parenchymal Splenic Metastasis is an Independent Negative Predictor of Overall Survival in Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer.
- Covered esophageal self-expandable metal stents in the nonoperative management of postoperative colorectal anastomotic leaks.
- Re: "Pelvic exenteration with curative intent for recurrent uterine malignancies".
- Five-Year Outcomes of Adjuvant Carboplatin/Paclitaxel Chemotherapy and Intravaginal Radiation for Stage I-II Papillary Serous Endometrial Cancer.
- Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian Cancer.
- Reproductive outcomes of patients undergoing radical trachelectomy for early-stage Cervical cancer.
- Proceedings from the 9th International Conference on Ovarian Cancer.
- Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial Cancer.
- Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed Uterine leiomyosarcoma.
- Robotic-Assisted Surgery in Gynecologic Oncology: A Society of Gynecologic Oncology Consensus Statement Developed by the Society of Gynecologic Oncology's Clinical Pra...
- CA125 Regression in Ovarian Cancer Patients Treated with Intravenous versus Intraperitoneal Platinum-Based Chemotherapy: A Gynecologic Oncology Group Study.
- Pelvic exenteration with curative intent for recurrent uterine malignancies.
- Treatment of Locally Recurrent Mucosal Melanoma With Topical Imiquimod.
- The role of cytoreductive surgery for newly diagnosed advanced-stage Uterine carcinosarcoma.
- An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal Carcinoma treated with primary debulking surgery (PDS) during an identical time period...
- Neuroendocrine tumors of the gynecologic Tract: A Society of Gynecologic Oncology (SGO) clinical document.
- Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal Cancers.
- Current and future directions of clinical trials for ovarian Cancer.
- Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or Cervical cancers.
- Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying Carcinoma risk.
- The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced Ovarian, tubal, an...
- Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for adva...
- The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial Cancer patients with negative pelvic lymph nodes.
- Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian Cancer.
- Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, Fallopian tube, or ...
- Ovarian Cancer cytoreductive surgery in the elderly.
- The role of cytoreductive surgery for colon Cancer metastatic to the ovary.
- Centralization of care for patients with advanced-stage ovarian Cancer: a cost-effectiveness analysis.
- Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian Cancer.
- Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier: a cost-effectiveness analysis.
- Secondary cytoreductive surgery for localized, recurrent epithelial ovarian Cancer: analysis of prognostic factors and survival outcome.
- Tertiary cytoreductive surgery in recurrent ovarian Cancer: selection criteria and survival outcome.
- Uterine Cancer in Maryland: impact of surgeon case volume and other prognostic factors on short-term mortality.
- Cost-effectiveness of routine vaginal cytology for endometrial Cancer surveillance.
- Salvage cytoreductive surgery for recurrent endometrial Cancer.
- Risk of epithelial ovarian Cancer recurrence in patients with rising serum CA-125 levels within the normal range.
- Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
- Surgical care of elderly women with ovarian Cancer: a population-based perspective.
- Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial Cancer.
- Laparoscopic lymphadenectomy for gynecologic malignancies using ultrasonically activated shears: analysis of first 100 cases.
- Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent Carcinoma of the cervix: a New York Gynecologic Oncology Group study.
- Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.
- Choice of normal ovarian control influences determination of differentially expressed genes in ovarian Cancer expression profiling studies.
- CL100 expression is down-regulated in advanced epithelial ovarian Cancer and its re-expression decreases its malignant potential.
Schools
Boston University School Of Medicine
Procedures Preformed
- Abdominal Hysterectomy With Robotic Assistance
- Colpopexy
- Colpopexy With Robotic Assistance
- Colporrhaphy
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Fellow (FACOG)
Education
-
Johns Hopkins University -
Boston University School of Medicine
Hospital
-
Bellevue Hospital Center -
Memorial Sloan-Kettering Cancer Center
Helpful Reviews
Similar Doctors
|
Dr. Sharon Cote, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard R. Egre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven F. Palter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald M. Siegel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mitchell S. Kramer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maritza Martinez, MD
This Doctor is OpenDoctor Recommended.
|